Literature DB >> 15165367

A no-laminectomy spinal cord compression injury model in mice.

Huaxin Sheng1, Haichen Wang, Hercilia M Homi, Ivan Spasojevic, Ines Batinic-Haberle, Robert D Pearlstein, David S Warner.   

Abstract

The purpose of this study was to develop a minimally invasive recovery model of spinal cord injury in the C57Bl/6J mouse. Without laminectomy, the epidural space was exposed by disruption of the T10-T11 interspinous ligament. Perpendicular to the rostral-caudal axis of the spine, a 1.5-mm silicone tube (O.D. 0.047 in.) was placed in the T11 epidural space. Prior to placement, a suture was passed through the tube allowing withdrawal of the tube after discontinuation of anesthesia. After 1, 30, 60, or 120 min (n = 5-8) of spinal cord compression (SCC), the tube was withdrawn. Neurological function was measured at 1, 3, 7, and 14 days after injury followed by histologic analysis. BBB locomotor score, rotarod latency, and screen grasping were worsened in a SCC duration-dependent manner (p < 0.0001). With increasing SCC duration, the number of histologically normal neurons in the ventral horns decreased (p < 0.0001) while the cross-sectional area of spinal cord with pancellular necrosis increased (p < 0.0001). Increased duration of SCC caused progressive rostral-caudal spread of histologic damage. The results indicate that this is a simple, reliable model with neurologic and histologic injury highly dependent on SCC duration. This model may be useful for study of spinal cord injury in genetically modified mice in the absence of anesthetic confounds while leaving the vertebral column intact.

Entities:  

Mesh:

Year:  2004        PMID: 15165367     DOI: 10.1089/089771504774129928

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  5 in total

1.  Oncostatin M reduces lesion size and promotes functional recovery and neurite outgrowth after spinal cord injury.

Authors:  Helena Slaets; Sofie Nelissen; Kris Janssens; Pia M Vidal; Evi Lemmens; Piet Stinissen; Sven Hendrix; Niels Hellings
Journal:  Mol Neurobiol       Date:  2014-07-05       Impact factor: 5.590

Review 2.  What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?

Authors:  Robert A Watson; Trevor M Yeung
Journal:  BMC Neurol       Date:  2011-09-23       Impact factor: 2.474

3.  Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Authors:  Jae Kyu Ryu; Mark A Petersen; Sara G Murray; Kim M Baeten; Anke Meyer-Franke; Justin P Chan; Eirini Vagena; Catherine Bedard; Michael R Machado; Pamela E Rios Coronado; Thomas Prod'homme; Israel F Charo; Hans Lassmann; Jay L Degen; Scott S Zamvil; Katerina Akassoglou
Journal:  Nat Commun       Date:  2015-09-10       Impact factor: 14.919

4.  Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure.

Authors:  Peter E Batchelor; Taryn E Wills; Peta Skeers; Camila R Battistuzzo; Malcolm R Macleod; David W Howells; Emily S Sena
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

5.  Standardization of a spinal cord lesion model and neurologic evaluation using mice.

Authors:  Paulo Alvim Borges; Alexandre Fogaça Cristante; Tarcísio Eloy Pessoa de Barros-Filho; Renato Jose Mendonça Natalino; Gustavo Bispo Dos Santos; Raphael Marcus Marcon
Journal:  Clinics (Sao Paulo)       Date:  2018-03-15       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.